Off-label drug information: regulation, distribution, evaluation, and related controversies.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. Short-term effects of intravitreal ranibizumab and bevacizumab administration on 24-h ambulatory blood pressure monitoring recordings in normotensive patients with age-related macular degeneration.Eye (London, England) · 2017
   Trial
2. Real-world treatment outcomes of medicines used in special situations (off-label and compassionate use) in oncology and hematology: A retrospective study from a comprehensive cancer institution.Cancer medicine · 2023
   Article
3. DrugCentral 2023 extends human clinical data and integrates veterinary drugs.Nucleic acids research · 2023
   Article
4. The Use of Psychotropic Medication in Pediatric Oncology for Acute Psychological and Psychiatric Problems: Balancing Risks and Benefits.Children (Basel, Switzerland) · 2022
   Review
5. Off-label use information in electronic drug information resources.Journal of the Medical Library Association : JMLA · 2022
   Article
6. Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs.JAMA network open · 2021
   Article
7. The evidence-based choice for antipsychotics in children and adolescents should be guaranteed.European journal of clinical pharmacology · 2019
   Review
8. Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.PLoS medicine · 2016
   Article
9. Drug utilisation and off-label use of medications in anaesthesia in surgical wards of a teaching hospital.Indian journal of anaesthesia · 2015
   Article
10. The effects of the natural enzyme, Pectinex Ultra SP-L, on human cell cultures and bacterial biofilms in vitro.BMC microbiology · 2014
    Article
11. Strategy to address innovative off-label medication use in China: grading management.European journal of clinical pharmacology · 2014
    Article
12. Off-label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authorities.Journal of pharmacology & pharmacotherapeutics · 2014
    Article
13. Off-label prescriptions for adult neurological patients: a pilot survey in China.International journal of clinical pharmacy · 2012
    Article
14. Psychotropic drug treatments for people with autism and other developmental disorders: a primer for practicing behavior analysts.Behavior analysis in practice · 2010
    Article
15. Off-label use of drugs in regional anesthesia: A need for setting up policies.Journal of anaesthesiology, clinical pharmacology
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.